...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: "57% relative risk reduction of MACE in patients with diabetes mellitus (DM) and CVD..."

Thanks for the clarification BDZ....when I read sentences like the following:

"...genes mediating monocyte adhesion to endothelial cells in response to high glucose(HG) and dietary metabolite trimethyl-amine oxide 

That kind of heavy science causes my eyes to glaze over.  I've sure the  answer is painfully obvious to you, given your scientific background, but if you'd indulge me just a little further I do have a question.

I thought Apabetalone reduced MACE by 77% in the phase II post hoc analysis, not 57%....Is this difference simply the difference between 3 and 5 point MACE?

Share
New Message
Please login to post a reply